Min Jung Kim
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Min Jung Kim has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Jae Hun Kim
Department of Anesthesiology and Pain Medicine, Konkuk University Medical Center, Konkuk University School of Medicine, Seoul, Korea
3 shared publications - Hyun Woo Choi
Jeonbuk National University
2 shared publications - Jeong Tae Do
School of Advanced Biotechnology, Konkuk University, Seoul, Korea
2 shared publications - Jong-Soo Kim
Department of Neurosurgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
2 shared publications Sol Choi
Department of Animal Biotechnology, College of Animal Bioscience and Technology Konkuk University, Seoul, Republic of Korea
2 shared publications- Cheol Hwan Park
Department of Anesthesiology and Pain Medicine, Konkuk University School of Medicine, Seoul, Korea
1 shared publication
Latest Publications
- Open Access
- 1 October 2022
- Published by Korean Pain Society in The Korean Journal of Pain
- Vol. 35 (4) , 475-487
Actual situation and prescribing patterns of opioids by pain physicians in South Korea
Min Jung Kim, Ji Yeon Kim, Yun Hee Lim, Sung Jun Hong, Jae Hun Jeong, Hey Ran Choi, Sun Kyung Park, Jung Eun Kim, Min Ki Lee, and Jae Hun Kim. Korean J Pain 2022;35:475-87. https://doi.org/10.3344/kjp.2022.35.4.475
- 1 October 2022
- Published by Korean Pain Society in The Korean Journal of Pain
- Vol. 35 (4) , 475-487
Open AccessActual situation and prescribing patterns of opioids by pain physicians in South Korea
Min Jung Kim, Ji Yeon Kim, Yun Hee Lim, Sung Jun Hong, Jae Hun Jeong, Hey Ran Choi, Sun Kyung Park, Jung Eun Kim, Min Ki Lee, and Jae Hun Kim. Korean J Pain 2022;35:475-87. https://doi.org/10.3344/kjp.2022.35.4.475
- Open Access
- 1 April 2022
- Published by Korean Pain Society in The Korean Journal of Pain
- Vol. 35 (2) , 129-139
Radiation safety for pain physicians: principles and recommendations
Sewon Park, Minjung Kim, and Jae Hun Kim. Korean J Pain 2022;35:129-39. https://doi.org/10.3344/kjp.2022.35.2.129
- 1 April 2022
- Published by Korean Pain Society in The Korean Journal of Pain
- Vol. 35 (2) , 129-139
Open AccessRadiation safety for pain physicians: principles and recommendations
Sewon Park, Minjung Kim, and Jae Hun Kim. Korean J Pain 2022;35:129-39. https://doi.org/10.3344/kjp.2022.35.2.129
- Open Access
- 30 October 2021
- Published by The Korean Society of Anesthesiologists in Anesthesia and Pain Medicine
- Vol. 16 (4) , 387-390
Dorsal root ganglion stimulation combined with spinal cord stimulation for effective treatment of postherpetic neuralgia - A case report -
Background: Although spinal cord stimulation (SCS) can be a treatment option for intractable postherpetic neuralgia (PHN), obtaining proper stimulation at the thoracic dermatome is difficult. Dorsal root ganglion (DRG) stimulation may be an effective treatment for patients with insufficient efficacy in SCS only.Case: A 54-year-old man with intractable PHN was referred to our clinic. Pain was localized to the distribution of the T1–3 dermatomes. SCS trial was conducted, and lead was placed within the epidural space over the C6–T1 level; however, the stimulation was inadequate for his pain site. Therefore, another lead was placed within the left T1 and T2 DRG for trial, and T1 DRG stimulation provided adequate stimulation. T1 DRG stimulation and SCS could cover the entire pain site with paresthesia, and his pain was decreased by over 50%.Conclusions: DRG stimulation combined with SCS may be a good treatment option for intractable thoracic PHN.
- 30 October 2021
- Published by The Korean Society of Anesthesiologists in Anesthesia and Pain Medicine
- Vol. 16 (4) , 387-390
Open AccessDorsal root ganglion stimulation combined with spinal cord stimulation for effective treatment of postherpetic neuralgia - A case report -
Background: Although spinal cord stimulation (SCS) can be a treatment option for intractable postherpetic neuralgia (PHN), obtaining proper stimulation at the thoracic dermatome is difficult. Dorsal root ganglion (DRG) stimulation may be an effective treatment for patients with insufficient efficacy in SCS only.Case: A 54-year-old man with intractable PHN was referred to our clinic. Pain was localized to the distribution of the T1–3 dermatomes. SCS trial was conducted, and lead was placed within the epidural space over the C6–T1 level; however, the stimulation was inadequate for his pain site. Therefore, another lead was placed within the left T1 and T2 DRG for trial, and T1 DRG stimulation provided adequate stimulation. T1 DRG stimulation and SCS could cover the entire pain site with paresthesia, and his pain was decreased by over 50%.Conclusions: DRG stimulation combined with SCS may be a good treatment option for intractable thoracic PHN.
- Open Access
- 15 September 2014
- Published by Oxford University Press (OUP) in Stem Cells
- Vol. 32 (10) , 2596-2604
Neural Stem Cells Differentiated From iPS Cells Spontaneously Regain Pluripotency
Differentiated somatic cells can be reprogrammed into pluripotent stem cells by transduction of exogenous reprogramming factors. After induced pluripotent stem (iPS) cells are established, exogenous genes are silenced. In the pluripotent state, retroviral genes integrated in the host genome are kept inactive through epigenetic transcriptional regulation. In this study, we tried to determine whether exogenous genes remain silenced or are reactivated upon loss of pluripotency or on differentiation using an in vitro system. We induced differentiation of iPS cells into neural stem cells (NSCs) in vitro; the NSCs appeared morphologically indistinguishable from brain-derived NSCs and stained positive for the NSC markers Nestin and Sox2. These iPS cell-derived NSCs (iPS-NSCs) were also capable of differentiating into all three neural subtypes. Interestingly, iPS-NSCs spontaneously formed aggregates on long-term culture and showed reactivation of the Oct4-GFP marker, which was followed by the formation of embryonic stem cell-like colonies. The spontaneously reverted green fluorescent protein (GFP)-positive (iPS-NSC-GFP+) cells expressed high levels of pluripotency markers (Oct4 and Nanog) and formed germline chimeras, indicating that iPS-NSC-GFP+ cells had the same pluripotency as the original iPS cells. The reactivation of silenced exogenous genes was tightly correlated with the downregulation of DNA methyltransferases (Dnmts) during differentiation of iPS cells. This phenomenon was not observed in doxycycline-inducible iPS cells, where the reactivation of exogenous genes could be induced only by doxycycline treatment. These results indicate that pluripotency can be regained through reactivation of exogenous genes, which is associated with dynamic change of Dnmt levels during differentiation of iPS cells. Stem Cells 2014;32:2596–2604
- 15 September 2014
- Published by Oxford University Press (OUP) in Stem Cells
- Vol. 32 (10) , 2596-2604
Open AccessNeural Stem Cells Differentiated From iPS Cells Spontaneously Regain Pluripotency
Differentiated somatic cells can be reprogrammed into pluripotent stem cells by transduction of exogenous reprogramming factors. After induced pluripotent stem (iPS) cells are established, exogenous genes are silenced. In the pluripotent state, retroviral genes integrated in the host genome are kept inactive through epigenetic transcriptional regulation. In this study, we tried to determine whether exogenous genes remain silenced or are reactivated upon loss of pluripotency or on differentiation using an in vitro system. We induced differentiation of iPS cells into neural stem cells (NSCs) in vitro; the NSCs appeared morphologically indistinguishable from brain-derived NSCs and stained positive for the NSC markers Nestin and Sox2. These iPS cell-derived NSCs (iPS-NSCs) were also capable of differentiating into all three neural subtypes. Interestingly, iPS-NSCs spontaneously formed aggregates on long-term culture and showed reactivation of the Oct4-GFP marker, which was followed by the formation of embryonic stem cell-like colonies. The spontaneously reverted green fluorescent protein (GFP)-positive (iPS-NSC-GFP+) cells expressed high levels of pluripotency markers (Oct4 and Nanog) and formed germline chimeras, indicating that iPS-NSC-GFP+ cells had the same pluripotency as the original iPS cells. The reactivation of silenced exogenous genes was tightly correlated with the downregulation of DNA methyltransferases (Dnmts) during differentiation of iPS cells. This phenomenon was not observed in doxycycline-inducible iPS cells, where the reactivation of exogenous genes could be induced only by doxycycline treatment. These results indicate that pluripotency can be regained through reactivation of exogenous genes, which is associated with dynamic change of Dnmt levels during differentiation of iPS cells. Stem Cells 2014;32:2596–2604
- Open Access
- 1 March 2014
- Published by Elsevier in Stem Cell Research
- Vol. 12 (2) , 506-516
Neural stem cells derived from epiblast stem cells display distinctive properties
- 1 March 2014
- Published by Elsevier in Stem Cell Research
- Vol. 12 (2) , 506-516
Open AccessNeural stem cells derived from epiblast stem cells display distinctive properties